Last reviewed · How we verify

NCT04095845

Conventional Total Hip Arthroplasty vs Mako Robotic-arm Assisted Total Hip Arthroplasty

Completed NA Last updated 9 July 2025
What this trial tests

NA trial testing CO THA in Osteoarthritis, Hip in 60 participants. Completed in 31 October 2024.

Timeline
9 November 2018
Primary endpoint
30 September 2024
31 October 2024

Quick facts

Lead sponsorUniversity College, London
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment60
Start date9 November 2018
Primary completion30 September 2024
Estimated completion31 October 2024
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University College, London

Who can join

Adults 18 to 80, any sex, with Osteoarthritis, Hip or Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall aim of this single-centre, prospective randomised controlled trial is to compare clinical, functional, and radiological outcomes in CO THA versus Mako THA. Patients undergoing Mako THA will form the investigation group and those undergoing CO THA will form the control group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Computerised tomography-based planning with conventional total hip arthroplasty versus robotic-arm assisted total hip arthroplasty: study protocol for a prospective randomised controlled trial.
    Kayani B, Konan S, Tahmassebi J, Ayuob A, et al · · 2020 · cited 3× · PMID 32912292 · DOI 10.1186/s13063-020-04702-7

Verify or expand the search:

Other recruiting trials for Osteoarthritis, Hip

Currently open trials in the same condition.

Other University College, London trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04095845.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing